Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Platelet Level During Radiotherapy Associated With Temozolomide in Patients Treated for Glioblastoma

NCT02617745 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT02617745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02617745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Platelet Level During Radiotherapy Associated With Temozolomide in Patients Treated for Glioblastoma
Lead sponsor
Centre Henri Becquerel
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2015
Completion date
June 5, 2024
Enrollment
244 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma